Copyright
©The Author(s) 2024.
World J Clin Cases. Mar 6, 2024; 12(7): 1235-1242
Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1235
Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1235
Parameters | ICU-AW group (n = 370) | Non-ICU-AW group (n = 693) | χ2/t/Z | P value |
Sex | 1.913 | 0.167 | ||
Male, n (%) | 235 (63.51) | 410 (59.16) | ||
Female, n (%) | 135 (36.49) | 283 (40.84) | ||
Age in yr, mean ± SD | 65.29 ± 18.72 | 58.58 ± 18.75 | 31.013 | 0.000 |
Sepsis, n (%) | 31 (8.38) | 31 (4.47) | 6.727 | 0.010 |
Multiple organ dysfunction syndrome, n (%) | 96 (25.95) | 68 (9.81) | 50.307 | 0.000 |
Hypoalbuminemia, n (%) | 275 (74.32) | 379 (54.69) | 67.286 | 0.000 |
Acute cardiogenic failure, n (%) | 157 (42.43) | 205 (29.58) | 18.005 | 0.000 |
Respiratory failure, n (%) | 231 (62.43) | 277 (39.97) | 83.798 | 0.000 |
Acute kidney injury, n (%) | 63 (17.03) | 47 (6.78) | 27.956 | 0.000 |
Anemia, n (%) | 191 (51.62) | 229 (33.04) | 35.942 | 0.000 |
Diffuse intravascular coagulation, n (%) | 5 (1.35) | 8 (1.15) | 0.077 | 0.781 |
Stress-related gastrointestinal bleeding, n (%) | 99 (26.76) | 74 (10.68) | 47.733 | 0.000 |
Shock, n (%) | 224 (60.54) | 276 (39.83) | 43.152 | 0.000 |
Hypertension, n (%) | 193 (52.16) | 263 (37.95) | 20.661 | 0.000 |
Diabetes, n (%) | 83 (22.43) | 133 (19.19) | 1.564 | 0.211 |
Coronary atherosclerotic heart disease, n (%) | 123 (33.24) | 132 (19.05) | 27.292 | 0.000 |
Malignant tumor, n (%) | 81 (21.89) | 144 (20.78) | 0.179 | 0.673 |
Rehabilitation therapy, n (%) | 20 (5.40) | 172 (24.82) | 93.687 | 0.000 |
Mechanical ventilation duration in h, M (QL, QU) | 114 (9.75, 250) | 0 (0, 21) | 29.905 | 0.000 |
Midazolam in mg, M (QL, QU) | 50 (0, 370) | 0 (0,20) | 127.872 | 0.000 |
Norepinephrine in mg, M (QL, QU) | 20 (0, 120) | 0 (0, 16) | 81.127 | 0.000 |
Length of intensive care unit stay in d, M (QL, QU) | 10 (6, 19) | 3 (1, 4) | 278.696 | 0.000 |
Samples | Measured results | Number of cases | Predicted results | ||
Non-ICU-AW | ICU-AW | Correct percentage (%) | |||
Training set | Non-ICU-AW | 503 | 443 | 60 | 88.1 |
ICU-AW | 257 | 45 | 212 | 82.5 | |
Total | 760 | 448 | 272 | 86.2 | |
Test set | Non-ICU-AW | 190 | 169 | 21 | 88.9 |
ICU-AW | 113 | 23 | 90 | 79.6 | |
Total | 303 | 192 | 111 | 85.5 |
Parameters | Importance | The importance of standardization (%) |
Age | 0.035 | 11.9 |
Sepsis | 0.052 | 17.6 |
Multiple organ dysfunction syndrome | 0.036 | 12.2 |
Hypoalbuminemia | 0.012 | 4.0 |
Acute cardiogenic failure | 0.023 | 7.8 |
Respiratory failure | 0.023 | 7.9 |
Acute kidney injury | 0.039 | 13.4 |
Anemia | 0.030 | 10.2 |
Stress-related gastrointestinal bleeding | 0.029 | 10.0 |
Shock | 0.034 | 11.4 |
Hypertension | 0.018 | 6.0 |
Coronary atherosclerotic heart disease | 0.019 | 6.5 |
Rehabilitation therapy | 0.042 | 14.2 |
Mechanical ventilation duration | 0.161 | 54.9 |
Sedative dose (Midazolam) | 0.098 | 33.4 |
Vasopressor medication dose (Epinephrine) | 0.057 | 19.5 |
Length of intensive care unit stay | 0.293 | 100.0 |
- Citation: Wang L, Long DY. Significant risk factors for intensive care unit-acquired weakness: A processing strategy based on repeated machine learning. World J Clin Cases 2024; 12(7): 1235-1242
- URL: https://www.wjgnet.com/2307-8960/full/v12/i7/1235.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i7.1235